fig5

Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy

Figure 5. Public data analysis verified the prognostic value of YAP1 and TIME characteristics of SCLC. (A) The public data analysis showed a negative correlation between OS and YAP1 expression levels in SCLC patients; (B) The correlation between infiltration levels of different immune cells and expression level YAP1; (C) Different infiltration levels of immune infiltrating cells between YAP1-low and YAP1-high groups. (*P < 0.05, **P < 0.01, ***P < 0.001). TIME: Tumor immune microenvironment; SCLC: small-cell lung cancer; OS: overall survival.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/